T-Robotics티로보틱스
117730 · KOSDAQ · ₩117730 · 티로보틱스
What brokers say about T-Robotics
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
T-Robotics is still loss-making and shrinking, though recent news flow is focused on a new U.S. patent and an AI manufacturing research role.
T-Robotics makes vacuum transfer robots and autonomous logistics robots for semiconductor and display manufacturers, with about 77% of sales exported. Trailing twelve-month revenue is ₩39.2B, with an operating loss of ₩15.5B and a net loss of ₩26.8B as of H1 2026. The share price is ₩12,450, down 13.4% over one month and 7.8% over one year, and well below its 52-week high of ₩30,900.
What stands out
- Revenue fell 27.8% in 2025 to ₩43.8B, and trailing revenue has continued to decline from the 2023 peak of ₩66.7B.
- Losses widened sharply: the 2025 net loss was ₩42.8B, and trailing operating margin is -39.7%.
- Trailing free cash flow is -₩6.5B, and borrowings of ₩15.6B exceed cash of ₩21.1B.
- Price-to-book is 4.4 and price-to-sales is 7.2, but there is no earnings-based valuation because profits are negative; no fair value model is provided.
- Foreign ownership fell slightly to 1.4% over 60 days, and the 20-day foreign flow was net selling of about ₩157M.
- Recent headlines centre on a U.S. patent for a glass substrate transfer robot and joining a ₩10.2B physical AI manufacturing research project, but the data does not show their financial effect.
What to watch
- The Q3 2026 quarterly report, to see whether revenue and losses continue the trend in the trailing figures.
- Further disclosures on the bond-with-warrants transaction and warrant exercises, which could affect share count and funding.
- Whether the new patent and research role translate into disclosed contracts or revenue; the data includes no forecasts.
Data as of Oct 23, 2026 · written 4d ago
This is not financial advice.
Also known as: T-Robotics / 티로보틱스 / 117730 / KRX:117730
Source: KRX statistical information